retatrutide side effects clinical trials 2025 What GLP‑3 Really Is: Triple‑Receptor Drug VisualAbstract: Retatrutide reduces body weight

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D2 /D3 receptor antagonist, in patients with gastroparesis

Sam Berkman, clinical professor of medicine at UCLA, explains why orthopedic surgery is a risk factor for blood clots and how patients can protect themselves from this potentially fatal complication

Why Proper GLP-1 Storage Is So Important GLP-1 receptor agonists are injectable peptides that mimic natural hormones in the body

It's a cool area to keep an eye on, especially if you're into natural ways to stay healthy

Click the button below to learn how you can sponsor the next edition of Big Pharma Sharma

Clinical trial enrolment via NIHR Be Part of Research, the ISRCTN registry, or ClinicalTrials.gov is the only sanctioned UK access route